Position in ASND
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$11,649,796
+$1,703,701 QoQ
Shares Held
43,678
+0.4% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#90
of 307 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 69%
Shared 0%
None 31%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NOMURA ASSET MANAGEMENT CO LTD holds $211,753,525 across 66 Biotechnology names. ASND ranks #5 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
120,235 | $59,724,331 | |
| 2 | ARGX |
Argenx SE
|
49,179 | $45,626,799 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
88,844 | $26,744,708 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
42,310 | $26,381,976 | |
| 5 | ASND |
Ascendis Pharma A/S
This page
|
43,678 | $11,649,796 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
51,993 | $9,737,249 | |
| 7 | INCY |
Incyte Corp
|
84,470 | $9,575,518 | |
| 8 | RPRX |
Royalty Pharma plc
|
167,680 | $9,401,817 |
All Filings in ASND
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,649,796 | 43,678 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $9,946,095 | 43,484 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $9,318,801 | 43,701 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $5,517,176 | 27,751 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,426,327 | 25,645 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $3,320,129 | 21,302 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $2,823,061 | 20,506 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $2,687,580 | 18,000 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $1,722,343 | 12,629 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,105,646 | 13,929 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,595,534 | 12,668 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $1,186,231 | 12,668 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $1,286,271 | 14,412 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,427,955 | 13,318 | Shares | Sole | 2025-01-10 | |
| 2022-12-31 | $1,547,387 | 12,670 | Shares | Sole | 2025-01-10 | |
| 2022-09-30 | $1,308,304 | 12,670 | Shares | Sole | 2025-01-10 | |
| 2022-06-30 | $1,177,803 | 12,670 | Shares | Sole | 2025-01-10 | |
| 2022-03-31 | $1,382,500 | 11,780 | Shares | Sole | 2025-01-10 | |
| 2021-12-31 | $1,431,399 | 10,640 | Shares | Sole | 2025-01-10 | |
| 2021-09-30 | $1,437,379 | 9,018 | Shares | Sole | 2025-01-10 | |
| 2021-06-30 | $1,068,449 | 8,122 | Shares | Sole | 2025-01-10 | |
| 2021-03-31 | $1,046,763 | 8,122 | Shares | Sole | 2025-01-10 | |
| 2020-12-31 | $0 | 0 | Shares | Sole | 2025-01-10 | |
| 2020-09-30 | $0 | 0 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||